However, this inhibition did not reach statistical significance, probably due to the high variability in the size of the xenografts and the relatively small number of animals in each group.
← all excerpts
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.
1
—
—